|
Market Closed -
Euronext Bruxelles
01:55:00 15/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 212.30 EUR | -3.10% |
|
-4.84% | -11.02% |
| 12/08 | Berenberg Adjusts UCB Forecasts After H1 Beat; Buy Reaffirmed | MT |
| 11/08 | UCB barely moves despite positive calls from ING and Berenberg |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UCB | Biopharmaceuticals | -3.10% | -4.84% | -11.02% | +9.26% | +116.28% | 46.87B |  | |  |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
